TWO SIGMA INVESTMENTS, LP - CORVUS PHARMACEUTICALS INC ownership

CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 39 filers reported holding CORVUS PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of CORVUS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$86,971
-52.3%
47,786
-53.4%
0.00%
Q1 2024$182,359
-42.7%
102,449
-43.3%
0.00%
-100.0%
Q4 2023$318,039
-20.2%
180,704
-33.8%
0.00%0.0%
Q3 2023$398,590
-31.5%
273,007
+7.4%
0.00%0.0%
Q2 2023$582,242
+213.6%
254,254
+24.6%
0.00%0.0%
Q1 2023$185,683
-22.3%
204,047
-27.4%
0.00%0.0%
Q4 2022$239,009
-32.1%
281,187
-34.6%
0.00%0.0%
Q3 2022$352,000
-1.4%
429,708
+19.0%
0.00%0.0%
Q2 2022$357,000
-56.8%
361,034
-28.4%
0.00%
-50.0%
Q1 2022$827,000
-63.1%
504,155
-45.8%
0.00%
-60.0%
Q4 2021$2,242,000
+229.7%
930,447
+562.5%
0.01%
+150.0%
Q3 2021$680,000
-17.8%
140,455
-54.6%
0.00%0.0%
Q2 2021$827,000
-23.0%
309,653
-11.2%
0.00%
-33.3%
Q1 2021$1,074,000
+678.3%
348,756
+586.9%
0.00%
+200.0%
Q2 2020$138,000
-34.0%
50,776
-48.8%
0.00%
-50.0%
Q1 2020$209,000
-64.6%
99,258
-8.6%
0.00%0.0%
Q4 2019$591,000
+206.2%
108,599
+69.6%
0.00%
+100.0%
Q3 2019$193,000
+10.3%
64,048
+36.6%
0.00%0.0%
Q2 2019$175,000
-31.9%
46,904
-26.6%
0.00%0.0%
Q1 2019$257,000
+2.0%
63,861
-7.0%
0.00%0.0%
Q4 2018$252,00068,7000.00%
Other shareholders
CORVUS PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
ADAMS STREET PARTNERS LLC 3,275,616$8,910,0001.84%
Novo Holdings A/S 2,927,560$7,963,0000.51%
Puissance Capital Management LP 38,010$103,0000.44%
CHI Advisors LLC 364,132$990,0000.39%
BVF INC/IL 1,742,112$4,739,0000.29%
Orbimed Advisors 6,767,584$18,408,0000.26%
EcoR1 Capital, LLC 737,612$2,006,0000.15%
Hikari Power Ltd 60,959$166,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 133,700$364,0000.01%
MILLENNIUM MANAGEMENT LLC 1,192,742$3,244,0000.00%
View complete list of CORVUS PHARMACEUTICALS INC shareholders